We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Accutane Label Didn't Adequately Warn, NJ Panel Says

Law360, New York (July 25, 2017, 6:19 PM EDT) -- The New Jersey Appellate Division on Tuesday upended court victories for Hoffman-La Roche Inc. and Roche Laboratories Inc. in hundreds of cases over the adverse affects of Accutane, ruling that the drug maker didn’t provide adequate warning in some cases and that a lower court wrongly applied New Jersey law in others.

The three-judge panel’s ruling in the multidistrict litigation handed a victory to consumers who alleged they developed inflammatory bowel disease after using the acne drug, addressing more than 530 cases filed on behalf of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.